Jun 7, 2011 07:41AM Needham & Company Maintains a 'Hold' on Warner Chilcott (WCRX); Warning Letter Could Complicate “Sweetest” Doryx 150mg Settlement Outcomes

Jun 7, 2011 07:39AM Needham & Company Maintains a 'Strong Buy' on Mylan (MYL); Likely Shared Exclusivity Slot Could Result in Upside Scenarios Following IPXL News

Feb 28, 2011 08:05AM Needham & Company Maintains a 'Strong Buy' on Mylan (MYL); Generic Diovan HCT Exclusivity Suggests Dramatically Improved 2012-2013 EPS Visibility

Feb 25, 2011 08:39AM Needham & Company Maintains a 'Strong Buy' on Mylan (MYL); U.S. Generic Fundamental Tailwinds Remain Strong; Current Euro Discount Affords Attractive Accumulation Opportunity

Dec 14, 2010 08:21AM Needham & Company Maintains a 'Strong Buy' on Mylan (MYL); Less Can Be More; Valuation, Still Haunted By Ghost of Leverage Past

Jul 15, 2010 08:14AM Needham & Company Maintains a 'Strong Buy' on Mylan (MYL); Bioniche Acquisition Doesn’t Cure European Hangover But Adds Solid Long-Term Growth Vehicle

Jul 13, 2010 07:29AM Needham & Company Maintains a 'Strong Buy' on Mylan (MYL); Receives Final Approval for Generic Oracea Potentially Setting Up Exclusivity Launch

Jan 8, 2010 10:51AM Notable Analyst Rating Changes 1/8: HAL, AMAT, JCP, AGU, ESV, RDN, More Upgraded; M, KO, STX, ERIC, WEN, PCS, More Downgraded

Sep 25, 2008 07:55AM Needham & Co Initiates Coverage on Drugs - Generic